China Chemical & Pharmaceutical Co Ltd
TWSE:1701
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Chemical & Pharmaceutical Co Ltd
Accounts Receivables
China Chemical & Pharmaceutical Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Chemical & Pharmaceutical Co Ltd
TWSE:1701
|
Accounts Receivables
NT$1.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Accounts Receivables
NT$1.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Accounts Receivables
NT$612.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-3%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Accounts Receivables
NT$6.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Accounts Receivables
NT$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Accounts Receivables
NT$6.5m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
China Chemical & Pharmaceutical Co Ltd
Glance View
China Chemical & Pharmaceutical Co., Ltd. engages in the business of buying, selling, manufacturing, importing, and exporting pharmaceutical products. The company is headquartered in Taipei City, Taipei. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The firm operates businesses in Taiwan and Mainland China.
See Also
What is China Chemical & Pharmaceutical Co Ltd's Accounts Receivables?
Accounts Receivables
1.6B
TWD
Based on the financial report for Jun 30, 2024, China Chemical & Pharmaceutical Co Ltd's Accounts Receivables amounts to 1.6B TWD.
What is China Chemical & Pharmaceutical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
4%
Over the last year, the Accounts Receivables growth was -3%. The average annual Accounts Receivables growth rates for China Chemical & Pharmaceutical Co Ltd have been -4% over the past three years , -1% over the past five years , and 4% over the past ten years .
